UBS Group’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.2K | Sell |
39,882
-61,896
| -61% | -$112K | ﹤0.01% | 6217 |
|
|
2025
Q1 | $207K | Buy |
101,778
+21,972
| +28% | +$44.6K | ﹤0.01% | 5299 |
|
|
2024
Q4 | $478K | Buy |
79,806
+78,979
| +9,550% | +$473K | ﹤0.01% | 4728 |
|
|
2024
Q3 | $8.07K | Sell |
827
-2,453
| -75% | -$23.9K | ﹤0.01% | 6644 |
|
|
2024
Q2 | $67.2K | Sell |
3,280
-5,917
| -64% | -$121K | ﹤0.01% | 5313 |
|
|
2024
Q1 | $415K | Buy |
9,197
+6,177
| +205% | +$279K | ﹤0.01% | 4231 |
|
|
2023
Q4 | $143K | Sell |
3,020
-1,893
| -39% | -$89.4K | ﹤0.01% | 4793 |
|
|
2023
Q3 | $199K | Sell |
4,913
-2,021
| -29% | -$81.8K | ﹤0.01% | 4283 |
|
|
2023
Q2 | $739K | Sell |
6,934
-3,084
| -31% | -$329K | ﹤0.01% | 3532 |
|
|
2023
Q1 | $2.99M | Buy |
10,018
+1,317
| +15% | +$393K | ﹤0.01% | 2244 |
|
|
2022
Q4 | $2.99M | Sell |
8,701
-261
| -3% | -$89.7K | ﹤0.01% | 2232 |
|
|
2022
Q3 | $1.7M | Buy |
8,962
+1,648
| +23% | +$312K | ﹤0.01% | 2464 |
|
|
2022
Q2 | $1.54M | Sell |
7,314
-3,971
| -35% | -$838K | ﹤0.01% | 2565 |
|
|
2022
Q1 | $3.78M | Sell |
11,285
-1,211
| -10% | -$405K | ﹤0.01% | 2152 |
|
|
2021
Q4 | $4.06M | Sell |
12,496
-987
| -7% | -$321K | ﹤0.01% | 2285 |
|
|
2021
Q3 | $6.55M | Buy |
13,483
+3,445
| +34% | +$1.67M | ﹤0.01% | 1779 |
|
|
2021
Q2 | $4.67M | Sell |
10,038
-2,298
| -19% | -$1.07M | ﹤0.01% | 2071 |
|
|
2021
Q1 | $8.52M | Buy |
12,336
+6,589
| +115% | +$4.55M | ﹤0.01% | 1557 |
|
|
2020
Q4 | $4.25M | Buy |
5,747
+253
| +5% | +$187K | ﹤0.01% | 1984 |
|
|
2020
Q3 | $3.81M | Buy |
5,494
+439
| +9% | +$305K | ﹤0.01% | 1911 |
|
|
2020
Q2 | $4.29M | Sell |
5,055
-353
| -7% | -$299K | ﹤0.01% | 1699 |
|
|
2020
Q1 | $1.93M | Sell |
5,408
-410
| -7% | -$147K | ﹤0.01% | 2191 |
|
|
2019
Q4 | $1.36M | Buy |
5,818
+824
| +16% | +$193K | ﹤0.01% | 3083 |
|
|
2019
Q3 | $563K | Buy |
4,994
+271
| +6% | +$30.6K | ﹤0.01% | 3633 |
|
|
2019
Q2 | $828K | Buy |
4,723
+30
| +0.6% | +$5.26K | ﹤0.01% | 3177 |
|
|
2019
Q1 | $743K | Buy |
4,693
+3,898
| +490% | +$617K | ﹤0.01% | 3117 |
|
|
2018
Q4 | $49K | Buy |
795
+551
| +226% | +$34K | ﹤0.01% | 5204 |
|
|
2018
Q3 | $30K | Buy |
244
+44
| +22% | +$5.41K | ﹤0.01% | 5631 |
|
|
2018
Q2 | $29K | Buy |
200
+34
| +20% | +$4.93K | ﹤0.01% | 5491 |
|
|
2018
Q1 | $27K | Buy |
+166
| New | +$27K | ﹤0.01% | 5312 |
|